课题基金 / 基金详情

Disability and Health Outcomes in COPD

Disability and Health Outcomes in COPD
慢性阻塞性肺病的残疾和健康结果
批准号:
7434360
负责人:
Paul D Blanc
金额:
$50.42万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2011-06-30

项目摘要

项目成果

Paul D Blanc的其他基金

相似基金

相关文献

中文摘要
翻译
DESCRIPTION (provided by applicant): Background. COPD is a common chronic health condition. Because current medical treatments have minimal impact on disease progression, a strategy to prevent COPD-related disability would have important clinical and public health benefits. Study Aims. To elucidate the disablement process, we will test a specific conceptual model of how disability develops in COPD. The aims are: (1) To evaluate the impact of respiratory impairment, especially pulmonary function impairment, on the risk of functional limitation in COPD. Using a control group, to elucidate the prevalence of respiratory impairment, functional limitation, and disability that is directly attributable to COPD. (2) In adults with COPD, to delineate the longitudinal effect of functional limitation on the risk of incident disability. We hypothesize that development of functional limitation, and not pulmonary function impairment, is the major determinant of disability. (3) To determine the prospective impact of disability on the risk of future adverse health outcomes. Methods. We will assemble a prospective cohort of 1200 randomly sampled adults with COPD who are members of a large regional health maintenance organization. A matched control group of 300 subjects will be recruited. Subjects will undergo a detailed physical assessment that measures respiratory impairment (e.g., pulmonary function) and functional limitation (e.g., lower extremity function, muscle strength, exercise performance, and cognitive function). Structured telephone interviews will ascertain disability outcomes at baseline and 18-month prospective follow-up. We will also study the modulating effects of specific risk factors and protective factors on the progression from functional limitation to COPD-related disability, including psychological factors, environmental exposures, and health care process factors. Significance. Elucidation of the disablement process is the first step toward designing clinical and public health interventions that target reduction of disability in COPD. By determining the pathway from functional limitation to disability, our goal is to provide a scientific basis for screening and prevention of disability among persons with COPD. Based on this work, intervention strategies can be designed that target reduction of functional limitation and disability to improve downstream health outcomes.
英文摘要
DESCRIPTION (provided by applicant): Background. COPD is a common chronic health condition. Because current medical treatments have minimal impact on disease progression, a strategy to prevent COPD-related disability would have important clinical and public health benefits. Study Aims. To elucidate the disablement process, we will test a specific conceptual model of how disability develops in COPD. The aims are: (1) To evaluate the impact of respiratory impairment, especially pulmonary function impairment, on the risk of functional limitation in COPD. Using a control group, to elucidate the prevalence of respiratory impairment, functional limitation, and disability that is directly attributable to COPD. (2) In adults with COPD, to delineate the longitudinal effect of functional limitation on the risk of incident disability. We hypothesize that development of functional limitation, and not pulmonary function impairment, is the major determinant of disability. (3) To determine the prospective impact of disability on the risk of future adverse health outcomes. Methods. We will assemble a prospective cohort of 1200 randomly sampled adults with COPD who are members of a large regional health maintenance organization. A matched control group of 300 subjects will be recruited. Subjects will undergo a detailed physical assessment that measures respiratory impairment (e.g., pulmonary function) and functional limitation (e.g., lower extremity function, muscle strength, exercise performance, and cognitive function). Structured telephone interviews will ascertain disability outcomes at baseline and 18-month prospective follow-up. We will also study the modulating effects of specific risk factors and protective factors on the progression from functional limitation to COPD-related disability, including psychological factors, environmental exposures, and health care process factors. Significance. Elucidation of the disablement process is the first step toward designing clinical and public health interventions that target reduction of disability in COPD. By determining the pathway from functional limitation to disability, our goal is to provide a scientific basis for screening and prevention of disability among persons with COPD. Based on this work, intervention strategies can be designed that target reduction of functional limitation and disability to improve downstream health outcomes.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.amjmed.2008.04.030
发表时间: 2008-09
期刊: AMERICAN JOURNAL OF MEDICINE
影响因子: 5.9
作者: [Eisner, Mark D., Blanc, Paul D., Yelin, Edward H., Sidney, Stephen, Katz, Patricia P., Ackerson, Lynn, Lathon, Phenius, Tolstykh, Irina, Omachi, Theodore, Byl, Nancy, Iribarren, Carlos]
通讯作者: Iribarren, Carlos
The COPD Helplessness Index: a new tool to measure factors affecting patient self-management.
慢性阻塞性肺病无助指数:衡量影响患者自我管理因素的新工具。
DOI: 10.1378/chest.09-0764
发表时间: 2010
期刊: Chest
影响因子: 9.6
作者: [Omachi,TheodoreA, Katz,PatriciaP, Yelin,EdwardH, Iribarren,Carlos, Knight,SaraJ, Blanc,PaulD, Eisner,MarkD]
通讯作者: Eisner,MarkD
DOI: 10.1136/jech.2009.089722
发表时间: 2011-01
期刊: Journal of epidemiology and community health
影响因子: 6.3
作者: [Eisner MD, Blanc PD, Omachi TA, Yelin EH, Sidney S, Katz PP, Ackerson LM, Sanchez G, Tolstykh I, Iribarren C]
通讯作者: Iribarren C
DOI: 10.1136/thx.2008.099390
发表时间: 2009-01
期刊: Thorax
影响因子: 10
作者: [Blanc PD, Iribarren C, Trupin L, Earnest G, Katz PP, Balmes J, Sidney S, Eisner MD]
通讯作者: Eisner MD
9
    Military Service, Occupational Exposure, and Rheumatoid Arthritis Risk in Veterans
    Military Service, Occupational Exposure, and Rheumatoid Arthritis Risk in Veterans
    Occupational and Environmental Factors in Neurological Disease
    New Technologies, Novel Diseases; Industrial Illness in 20th Century Rayon Manufa
    海外基金